Xiangning Cui

1.6k total citations · 2 hit papers
34 papers, 1.2k citations indexed

About

Xiangning Cui is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Xiangning Cui has authored 34 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 9 papers in Pulmonary and Respiratory Medicine and 7 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Xiangning Cui's work include Traditional Chinese Medicine Analysis (4 papers), Cardiac Fibrosis and Remodeling (4 papers) and Mitochondrial Function and Pathology (3 papers). Xiangning Cui is often cited by papers focused on Traditional Chinese Medicine Analysis (4 papers), Cardiac Fibrosis and Remodeling (4 papers) and Mitochondrial Function and Pathology (3 papers). Xiangning Cui collaborates with scholars based in China. Xiangning Cui's co-authors include Mi Xiang, Chang Shang, Yingdong Lu, Laiyun Xin, Yuling Wang, Zihuan Shen, Zhilin Jiang, Hongchen Lin, Yan Wang and Yi Qu and has published in prestigious journals such as PLoS ONE, Heart and Pharmacological Research.

In The Last Decade

Xiangning Cui

33 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Role of Oxidative Stress in Reperfusion following Myocardial Ischemia and Its Treatments

2021 190 citations Mi Xiang, Yingdong Lu et al. Oxidative Medicine and Cellular Longevity profile →
The role of matrix metalloproteinase 9 in fibrosis diseases and its molecular mechanisms

2024 45 citations Yuling Wang, Chen Chen et al. Biomedicine & Pharmacotherapy profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xiangning Cui China	18	537	171	158	145	142	34	1.2k
Rodrigo Carrasco Chile	16	428 0.8×	140 0.8×	236 1.5×	97 0.7×	133 0.9×	27	1.3k
Ying Tan China	22	927 1.7×	180 1.1×	184 1.2×	238 1.6×	135 1.0×	36	1.7k
Qiao Yang China	19	484 0.9×	174 1.0×	220 1.4×	131 0.9×	93 0.7×	48	1.1k
Wenqun Li China	22	712 1.3×	166 1.0×	272 1.7×	163 1.1×	127 0.9×	58	1.5k
Ajoe John Kattoor United States	9	581 1.1×	102 0.6×	234 1.5×	201 1.4×	67 0.5×	25	1.7k
Lan Sun China	25	598 1.1×	155 0.9×	215 1.4×	177 1.2×	90 0.6×	66	1.6k
Gehan H. Heeba Egypt	25	458 0.9×	78 0.5×	146 0.9×	87 0.6×	184 1.3×	50	1.5k
Lei Du China	28	761 1.4×	104 0.6×	81 0.5×	152 1.0×	103 0.7×	44	1.7k
Chang Shang China	10	344 0.6×	111 0.6×	77 0.5×	101 0.7×	108 0.8×	13	742
Yingdong Lu China	15	462 0.9×	136 0.8×	150 0.9×	117 0.8×	109 0.8×	28	871

Countries citing papers authored by Xiangning Cui

Since Specialization

Citations

This map shows the geographic impact of Xiangning Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiangning Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiangning Cui more than expected).

Fields of papers citing papers by Xiangning Cui

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiangning Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiangning Cui. The network helps show where Xiangning Cui may publish in the future.

Co-authorship network of co-authors of Xiangning Cui

This figure shows the co-authorship network connecting the top 25 collaborators of Xiangning Cui. A scholar is included among the top collaborators of Xiangning Cui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiangning Cui. Xiangning Cui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Liu, Qi, et al.. (2024). Genetic prediction of the causal relationship between schizophrenia and tumors: a Mendelian randomized study. Frontiers in Oncology. 14. 1321445–1321445.

Wang, Yuling, Chen Chen, Zihuan Shen, et al.. (2024). The role of matrix metalloproteinase 9 in fibrosis diseases and its molecular mechanisms. Biomedicine & Pharmacotherapy. 171. 116116–116116. 45 indexed citations breakdown →

Xiang, Mi, Xin Zhao, Yingdong Lu, et al.. (2023). Modified Linggui Zhugan Decoction protects against ventricular remodeling through ameliorating mitochondrial damage in post-myocardial infarction rats. Frontiers in Cardiovascular Medicine. 9. 1038523–1038523. 4 indexed citations

Cui, Xiangning, et al.. (2022). Plin5, a New Target in Diabetic Cardiomyopathy. Oxidative Medicine and Cellular Longevity. 2022(1). 2122856–2122856. 16 indexed citations

Cui, Xiangning, et al.. (2022). Efficacy and safety of whole-lung lavage for pulmonary alveolar proteinosis: a protocol for a systematic review and meta-analysis. BMJ Open. 12(4). e057671–e057671. 2 indexed citations

Wang, Yan, et al.. (2022). Neuregulin-1, a potential therapeutic target for cardiac repair. Frontiers in Pharmacology. 13. 945206–945206. 34 indexed citations

Cui, Xiangning, Yang Zhang, Yingdong Lu, & Mi Xiang. (2022). ROS and Endoplasmic Reticulum Stress in Pulmonary Disease. Frontiers in Pharmacology. 13. 879204–879204. 43 indexed citations

Lv, Jiayu, Shuqing Shi, Bingxuan Zhang, et al.. (2022). Role of puerarin in pathological cardiac remodeling: A review. Pharmacological Research. 178. 106152–106152. 43 indexed citations

Lu, Yingdong, Mi Xiang, Laiyun Xin, et al.. (2022). Qiliqiangxin Modulates the Gut Microbiota and NLRP3 Inflammasome to Protect Against Ventricular Remodeling in Heart Failure. Frontiers in Pharmacology. 13. 905424–905424. 16 indexed citations

10.

Jiang, Zhilin, et al.. (2022). Roles and mechanisms of puerarin on cardiovascular disease：A review. Biomedicine & Pharmacotherapy. 147. 112655–112655. 56 indexed citations

11.

Lu, Ziwen, Lei Wang, Yangyang Jiang, et al.. (2022). Abnormalities of hippocampus and frontal lobes in heart failure patients and animal models with cognitive impairment or depression: A systematic review. PLoS ONE. 17(12). e0278398–e0278398. 8 indexed citations

12.

Zhang, Minyu, Feifei Guo, Xianyu Li, et al.. (2022). Yi-Xin-Shu capsule ameliorates cardiac hypertrophy by regulating RB/HDAC1/GATA4 signaling pathway based on proteomic and mass spectrometry image analysis. Phytomedicine. 103. 154185–154185. 18 indexed citations

13.

Lu, Yingdong, Yang Zhang, Xin Zhao, et al.. (2022). Microbiota-derived short-chain fatty acids: Implications for cardiovascular and metabolic disease. Frontiers in Cardiovascular Medicine. 9. 900381–900381. 56 indexed citations

14.

Cui, Xiangning, et al.. (2022). The Molecular Mechanisms of Defective Copper Metabolism in Diabetic Cardiomyopathy. Oxidative Medicine and Cellular Longevity. 2022(1). 5418376–5418376. 47 indexed citations

15.

Shen, Zihuan, Mi Xiang, Chen Chen, et al.. (2022). Glutamate excitotoxicity: Potential therapeutic target for ischemic stroke. Biomedicine & Pharmacotherapy. 151. 113125–113125. 134 indexed citations

16.

Zhang, Yang, Laiyun Xin, Mi Xiang, et al.. (2021). The molecular mechanisms of ferroptosis and its role in cardiovascular disease. Biomedicine & Pharmacotherapy. 145. 112423–112423. 116 indexed citations

17.

Xin, Laiyun, Jialiang Gao, Hongchen Lin, et al.. (2020). Regulatory Mechanisms of Baicalin in Cardiovascular Diseases: A Review. Frontiers in Pharmacology. 11. 583200–583200. 64 indexed citations

18.

Lu, Yingdong, Zhilin Jiang, Dandan Zhang, et al.. (2020). Guanxinshutong Alleviates Atherosclerosis by Suppressing Oxidative Stress and Proinflammation in ApoE^−/− Mice. Evidence-based Complementary and Alternative Medicine. 2020(1). 1219371–1219371. 6 indexed citations

19.

Cui, Xiangning, Jiän Zhang, Yubo Li, et al.. (2015). Effects of Qili Qiangxin Capsule on AQP2, V2R, and AT1R in Rats with Chronic Heart Failure. Evidence-based Complementary and Alternative Medicine. 2015. 1–11. 13 indexed citations

20.

Wang, Chunxue, et al.. (2006). Management of SAH with traditional Chinese medicine in China. Neurological Research. 28(4). 436–444. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact